Marksans Pharma’s arm gets marketing authorization for four products

02 Jul 2024 Evaluate

Marksans Pharma’s wholly owned subsidiary – Relonchem has received marketing authorization from UKMHRA for Rasagiline Relonchem 1 mg Tablets, Olmesartan 10 mg Film-coated Tablets, Olmesartan 20 mg Film-coated Tablets and Olmesartan 40 mg Film-coated Tablets. 

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.

Marksans Pharma Share Price

203.30 8.35 (4.28%)
08-Apr-2025 11:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1690.20
Dr. Reddys Lab 1107.70
Cipla 1409.20
Lupin 1955.75
Zydus Lifesciences 848.75
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...